The New Radiolabeled Peptide (99m)TcEDDA/HYNIC-TOC: Is It a Feasible Choice for Diagnosing Gastroenteropancreatic NETs?

SIMPLE SUMMARY: Gastroenteropancreatic neuroendocrine tumors are a group of heterogenous tumors that account for about 60% of the neuroendocrine tumors diagnosed nowadays. They possess the capability to synthesize and secrete peptides and hormones that lead to their characteristic syndromes. One of...

Descripción completa

Detalles Bibliográficos
Autores principales: Gherghe, Mirela, Lazăr, Alexandra Maria, Stanciu, Adina Elena, Mutuleanu, Mario-Demian, Sterea, Maria-Carla, Petroiu, Cristina, Galeș, Laurenția Nicoleta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179571/
https://www.ncbi.nlm.nih.gov/pubmed/35681704
http://dx.doi.org/10.3390/cancers14112725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179571/
https://www.ncbi.nlm.nih.gov/pubmed/35681704
http://dx.doi.org/10.3390/cancers14112725

Ejemplares similares